Загрузка...
4-1BB enhancement of CAR T function requires NF-κB and TRAFs
Chimeric antigen receptors (CARs) have an antigen-binding domain fused to transmembrane, costimulatory, and CD3ζ domains. Two CARs with regulatory approval include a CD28 or 4-1BB costimulatory domain. While both CARs achieve similar clinical outcomes, biologic differences have become apparent but n...
Сохранить в:
| Опубликовано в: : | JCI Insight |
|---|---|
| Главные авторы: | , , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
American Society for Clinical Investigation
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6237232/ https://ncbi.nlm.nih.gov/pubmed/30232281 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.121322 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|